Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
Preferred Name | Gemifloxacin | |
Synonyms |
|
|
Definitions |
A fluoroquinolone antibiotic with antimicrobial property. Gemifloxacin enters bacterial cells by diffusion through integral membrane porin pathway before targeting both DNA gyrase and topoisomerase IV, two enzymes critical for DNA replication and repair. This agent binds to the DNA/DNA-gyrase complex and inhibits the A subunits of the enzyme thereby preventing the bacterial chromosome from rejoining. This interferes with DNA replication and repair processes as well as transcription, and ultimately leads to bacterial cell death. Gemifloxacin targets at both Gram-positive, -negative and atypical human pathogens. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C61775 |
|
CAS_Registry |
175463-14-6 204519-64-2
|
|
CHEBI_ID |
CHEBI:101853
|
|
Chemical_Formula |
C18H20FN5O4
|
|
code |
C61775
|
|
Contributing_Source |
FDA
|
|
definition |
A fluoroquinolone antibiotic with antimicrobial property. Gemifloxacin enters bacterial cells by diffusion through integral membrane porin pathway before targeting both DNA gyrase and topoisomerase IV, two enzymes critical for DNA replication and repair. This agent binds to the DNA/DNA-gyrase complex and inhibits the A subunits of the enzyme thereby preventing the bacterial chromosome from rejoining. This interferes with DNA replication and repair processes as well as transcription, and ultimately leads to bacterial cell death. Gemifloxacin targets at both Gram-positive, -negative and atypical human pathogens.
|
|
FDA_UNII_Code |
OKR68Y0E4T
|
|
Has_Salt_Form | ||
in_subset | ||
label |
Gemifloxacin
|
|
Legacy Concept Name |
Gemifloxacin
|
|
Preferred_Name |
Gemifloxacin
|
|
prefixIRI |
NCIT:C61775
|
|
prefLabel |
Gemifloxacin
|
|
Semantic_Type |
Pharmacologic Substance
|
|
UMLS_CUI |
C0533545
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping